Holen Sie sich die Stockscreener-App
199.64
1.93%
-3.92
Handel nachbörslich:
200.55
0.91
+0.46%
Insmed Inc Aktie (INSM) Neueste Nachrichten
INSM: TD Cowen Raises Price Target, Maintains Buy Rating | INSM Stock News - GuruFocus
How Insmed Incorporated (IM8N) stock performs in easing cyclesRate Hike & Daily Stock Trend Reports - newser.com
Will Insmed Incorporated (IM8N) stock recover faster than industryFed Meeting & High Accuracy Swing Entry Alerts - newser.com
Insmed wins first EU approval for non-cystic fibrosis bronchiectasis treatment - MarketScreener
Why Insmed Incorporated (IM8N) stock is listed among top recommendationsPortfolio Performance Report & AI Forecast Swing Trade Picks - newser.com
Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri - sharewise.com
Will Insmed Incorporated stock benefit from automationIndex Update & Accurate Entry/Exit Alerts - newser.com
From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews
Insider Sell: Leo Lee Sells 75,000 Shares of Insmed Inc (INSM) - GuruFocus
Building trade automation scripts for Insmed IncorporatedCPI Data & Proven Capital Preservation Methods - newser.com
Insmed director Anderson sells $1.96 million in stock By Investing.com - Investing.com South Africa
Insmed director Anderson sells $1.96 million in stock - Investing.com
Peering Into Insmed Inc's Recent Short Interest - Benzinga
Insmed (INSM) Gains EU Approval for First NCFB Treatment - GuruFocus
European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union - PR Newswire
Insmed (Nasdaq: INSM) BRINSUPRI Wins EU OK After 19.4% NCFB Exacerbation Reduction - Stock Titan
European Commission Approves Insmed's Chronic Lung Disease Treatment - MarketScreener
Insmed at Jefferies London: Transforming into a Multi-Franchise Entity By Investing.com - Investing.com Nigeria
Insmed at Jefferies London: Transforming into a Multi-Franchise Entity - Investing.com
INSM: Brensocatib and TPIP advances fuel growth, with major data and market expansions ahead - TradingView
Transcript : Insmed Incorporated Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 08 - MarketScreener
Here’s What Lifted Insmed Incorporated (INSM) in Q3 - Yahoo Finance
Insmed (INSM) Price Target Increased by 15.76% to 206.22 - Nasdaq
How Insmed Incorporated (IM8N) stock compares with tech leadersJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Insmed (BIT:1INSM) Price Target Increased by 19.33% to 179.30 - Nasdaq
Trend analysis for Insmed Incorporated this weekJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com
What drives Insmed Incorporated stock priceEconomic Impact on Stocks & Follow Top Performers in the Community - earlytimes.in
A Fresh Look at Insmed (INSM) Valuation After Recent Share Price Surge - Yahoo Finance
Insmed stock reaches 52-week high at 197.1 USD By Investing.com - Investing.com Nigeria
How Insmed Incorporated stock reacts to Fed rate cutsChart Signals & Comprehensive Market Scan Reports - newser.com
Insmed stock reaches 52-week high at 197.1 USD - Investing.com
What machine learning models say about Insmed IncorporatedPortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Why Insmed Incorporated is moving todayJuly 2025 Market Mood & AI Powered Market Entry Strategies - newser.com
Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good – Company Announcement - Financial Times
1.27%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):